June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Biomarkers in glaucoma and tinnitus suggest low nitric oxide bioavailability and excitotoxicity
Author Affiliations & Notes
  • Allison Loiselle
    Ophthalmology, University Medical Center Groningen, Groningen, Netherlands
    University of Groningen, Netherlands
  • Aruna Rikkers
    Ophthalmology, University Medical Center Groningen, Groningen, Netherlands
    University of Groningen, Netherlands
  • Nomdo M Jansonius
    Ophthalmology, University Medical Center Groningen, Groningen, Netherlands
    University of Groningen, Netherlands
  • Footnotes
    Commercial Relationships   Allison Loiselle, None; Aruna Rikkers, None; Nomdo Jansonius, None
  • Footnotes
    Support  Horizon 2020 grant No 661883 and Uitzicht grant No 2015-11
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 989. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Allison Loiselle, Aruna Rikkers, Nomdo M Jansonius; Biomarkers in glaucoma and tinnitus suggest low nitric oxide bioavailability and excitotoxicity. Invest. Ophthalmol. Vis. Sci. 2020;61(7):989.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Low nitric oxide (NO) bioavailability and oxidative stress may be common mechanisms behind glaucoma and tinnitus. NO itself diffuses quickly and is difficult to measure, however, certain metabolites can be measured as biomarkers of NO production. The aim of this study was to test these biomarkers of NO in glaucoma patients both with and without tinnitus.

Methods : Serum levels of asymmetric dimethylarginine (ADMA), L-arginine (ARG), L-ornithine (ORN), L-citrulline (CIT), L-glutamate (GLU), and L-glutamine (GLN) were assessed in 51 patients with primary open angle glaucoma. Of these, 25 patients had tinnitus and 26 did not; the groups were gender and age similar, and had a similar proton pump inhibitor intake. A Wilcoxon test was used to determine differences between the groups. In addition, patients were compared to reference values of the metabolites of interest in healthy people.

Results : Both GLN, GLU, and the GLN/GLU ratio were higher in those with tinnitus compared to those without tinnitus (P=0.001, P=0.039, P=0.027, respectively). Additionally, median ARG, ORN, and GLU for the 51 patients were outside the reference ranges for healthy people in the expected directions [ARG: 20 μmol/L, ref (20-95), ORN: 231 μmol/L, ref (39-151), GLU: 292 μmol/L, ref (13-113)].

Conclusions : Low ARG and high ORN suggest a decrease in NO bioavailability in all patients. The high GLU in all patients and relatively high GLN in tinnitus patients suggest an increase in excitotoxicity and oxidative stress. Low NO and high excitatory amino acids may be a common underlying mechanism between glaucoma and tinnitus.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×